Irbesartan lowers superoxide levels and increases nitric oxide bioavailability in blood vessels from spontaneously hypertensive stroke-prone rats
- 1 February 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 20 (2) , 281-286
- https://doi.org/10.1097/00004872-200202000-00018
Abstract
To determine the effects of the angiotensin II receptor antagonist irbesartan, the calcium-channel blocker amlodipine, and hydrochlorothiazide/hydralazine on superoxide, NAD(P)H oxidase and nitric oxide bioavailability in spontaneously hypertensive stroke-prone rats (SHRSP). Drugs or vehicle were administered for 8 weeks to SHRSP and blood pressure was measured weekly by tail-cuff plethysmography. After 8 weeks, superoxide levels in carotid arteries and aortas were measured by lucigenin chemiluminescence and p22phox expression quantified by immunohistochemistry. In vitro the effects of exposure to drugs and vehicle for 30 min and 4 h on superoxide levels and nitric oxide bioavailability were examined. The latter was expressed as the increase in contractile responses of carotid arteries to phenylephrine in the presence of the nitric oxide synthase inhibitor N G-nitro-l-arginine methyl ester (l-NAME). In vivo irbesartan, amlodipine and hydrochlorothiazide/hydralazine produced similar falls in blood pressure, from 162 ± 4 to 125 ± 5, 132 ± 4 and 131 ± 6 mmHg, respectively, but irbesartan caused a greater reduction in superoxide and p22phox; superoxide levels in carotid arteries being 3.1 ± 0.3, 1.1 ± 0.2, 1.9 ± 0.3 and 2.0 ± 0.3 nmoles/mg per min, respectively. In vitro 4 h exposure to irbesartan decreased superoxide levels in the aorta from 2.08 ± 0.68 to 1.48 ± 0.62 nmoles/mg per min and increased nitric oxide bioavailability in carotid arteries. Neither 30 min incubation with irbesartan nor 4 h with amlodipine or hydrochlorothiazide/hydralazine altered superoxide levels. These studies support the hypothesis that AT1 receptor blockade has beneficial effects on superoxide production and nitric oxide bioavailability above that of other classes of antihypertensive agents. Reduced expression of components of the NAD(P)H oxidase may contribute to these effects.Keywords
This publication has 29 references indexed in Scilit:
- Superoxide Excess in Hypertension and AgingHypertension, 2001
- Vascular NADH/NADPH Oxidase Is Involved in Enhanced Superoxide Production in Spontaneously Hypertensive RatsHypertension, 2000
- Superoxide Anion Production Is Increased in a Model of Genetic HypertensionHypertension, 1999
- Paracrine Role of Adventitial Superoxide Anion in Mediating Spontaneous Tone of the Isolated Rat Aorta in Angiotensin II-Induced HypertensionHypertension, 1999
- Role of NADH/NADPH Oxidase–Derived H 2 O 2 in Angiotensin II–Induced Vascular HypertrophyHypertension, 1998
- Losartan Reduces Phenylephrine Constrictor Response in Aortic Rings From Spontaneously Hypertensive RatsHypertension, 1996
- Cardiac and Vascular Effects of Long-term Losartan Treatment in Stroke-Prone Spontaneously Hypertensive RatsHypertension, 1996
- Blood Pressure in Genetically Hypertensive RatsHypertension, 1995
- Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition.Hypertension, 1993
- Captopril improves impaired endothelium-dependent vasodilation in hypertensive patients.Hypertension, 1992